Home › Funds › SUPERSTRING CAPITAL MANAGEMENT LP › BMEA
SUPERSTRING CAPITAL MANAGEMENT LP position in BMEA
BIOMEA FUSION INC · Health Care
SUPERSTRING CAPITAL MANAGEMENT LP reported holding 250,000 shares of BMEA (BIOMEA FUSION INC) in its Q2 2026 13F filing — a position valued at US$85K, representing 0.05% of its reported portfolio and ranking #31 among its reported holdings. SUPERSTRING CAPITAL MANAGEMENT LP has disclosed BMEA holdings in 7 of the last 9 reported quarters, going back to Q2 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How SUPERSTRING CAPITAL MANAGEMENT LP's BMEA position evolved
SUPERSTRING CAPITAL MANAGEMENT LP first disclosed a stake in BMEA in Q2 2024 at 167,110 shares (US$752K). The position peaked in Q3 2024 at 83,554 shares, worth US$844K. Across 7 filings, SUPERSTRING CAPITAL MANAGEMENT LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 250,000 shares valued at US$85K. Notable position changes include a 50% trim in Q3 2024 (shares fell 62% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 167.11K | $752.00K | New |
| Q3 2024 | 83.55K | $843.89K | Reduce |
| Q2 2025 | 250.00K | $450.00K | New |
| Q3 2025 | 250.00K | $505.00K | Hold |
| Q4 2025 | 250.00K | $310.00K | Hold |
| Q1 2026 | 250.00K | $382.50K | Hold |
| Q2 2026 | 250.00K | $85.31K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BMEA and 13F data
BMEA (BIOMEA FUSION INC) is a Health Care company. 13 other funds we track also report a position in BMEA — the largest reported positions include Aisling Capital Management LP (US$3.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BMEA
- Aisling Capital Management LP 2.05M sh · $3.01M · Q2 2026
More on SUPERSTRING CAPITAL MANAGEMENT LP
FAQ
How long has SUPERSTRING CAPITAL MANAGEMENT LP held BMEA?
SUPERSTRING CAPITAL MANAGEMENT LP has disclosed BMEA holdings in 7 of the last 9 reported quarters, going back to Q2 2024.
What is SUPERSTRING CAPITAL MANAGEMENT LP's current position in BMEA?
As of Q2 2026, SUPERSTRING CAPITAL MANAGEMENT LP holds 250.00K shares of BMEA (BIOMEA FUSION INC), valued at $85.31K, representing 0.05% of its reported portfolio and ranking #31.
Has SUPERSTRING CAPITAL MANAGEMENT LP been buying or selling BMEA?
In the latest 13F filing (Q2 2026), SUPERSTRING CAPITAL MANAGEMENT LP held unchanged its position in BMEA. The position peaked in Q3 2024 at 83.55K shares.
Which other funds hold BMEA?
Other major institutional holders of BMEA include Aisling Capital Management LP, among 13 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.